secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001193125-24-090787
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix raises ~$51.6M in oversubscribed common offering and convertible preferred placement
--------------------------------------------------------------------------------

- Net proceeds ~$51.6M from 17.4M shares common at $1.15/share and 760,857 Series A Preferred at $46/share.
- Series A Preferred automatically converts to 40 common shares per preferred share upon stockholder approval, up to 30.4M common shares.
- Management and directors participated in the private placement; 90-day lock-up on common shares.
- Funds to be used for commercial expansion, product pipeline, R&D, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312524090787/0001193125-24-090787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312524090787/d779805d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-090787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer